Azvudine and nirmatrelvir-ritonavir (Paxlovid) were widely used to treat patients with COVID-19 in China during the Omicron wave. However, the efficacy and safety of azvudine versus Paxlovid are poorly established. This study included 40,876 hospitalized patients with COVID-19 from eleven hospitals in Henan and Xinjiang Provinces, China.
View Article and Find Full Text PDFBackground: Despite substantial progress in reducing the global burden of chronic obstructive pulmonary disease (COPD), traditional methods to promote understanding and management of COPD are insufficient. We developed an innovative model based on the internet of things (IoT) for screening and management of COPD in primary healthcare (PHC).
Methods: Electronic questionnaire and IoT-based spirometer were used to screen residents.
Zhonghua Liu Xing Bing Xue Za Zhi
September 2007
Objective: To better understand the proportions of reported hepatitis B cases in pilot surveillance cites through investigation and laboratory testing.
Methods: To confirm the reported cases of hepatitis B by collecting blood specimen and laboratory testing on HBsAg, IgM of Anti-HBc, Anti-HAV in 18 pilot surveillance counties.
Results: Among 2858 cases of hepatitis B reported in 2006, 23.
Zhonghua Liu Xing Bing Xue Za Zhi
August 2007
Zhonghua Liu Xing Bing Xue Za Zhi
March 2004
Objective: To evaluate the authenticity of the parents' memory on their children's immunization status.
Methods: Two counties and 1 district in each of the 18 prefectures were selected, and parents of the children 1 - 2 years old, residents in counties or floating in district, were studied on the authenticity of their memory regarding their children's immunization status.
Results: The rates of inoculation with all the four expanded programme on immunization (EPI) vaccines were 89.